- Bone Health
- Immunology
- Hematology
- Respiratory
- Dermatology
- Diabetes
- Gastroenterology
- Neurology
- Oncology
- Ophthalmology
- Rare Disease
- Rheumatology
Instagram Pages
Here you can access stories featured on our instagram page. Want more biosimilar news? Sign up for our weekly newsletter, delivered to your inbox every Wednesday here.
More Research Finds Low Awareness of Biosimilars Among Oncology Providers
NHS Provides Update on Biosimilar Adalimumab With a Focus on ISRs
ye on Pharma: Biocon Reports Its Highest-Ever Revenue and Profit Growth for Q3
eview Points to Nocebo Effect as a Cause of Higher Discontinuation Rates for Biosimilars
Coherus Settles With AbbVie, Sues Amgen, Over Biosimilar Adalimumab
ncreases in Insulin Prices Drove Spending Over 4 Years, Report Says
uropean Report Says M&As Affecting Biosimilars Need Scrutiny
Drugs Targeted by Biosimilars Are Responsible for Some of the Highest Hospital Spending
Sanctions Against Samsung BioLogics Suspended Pending Court Ruling
ales of Oncology Reference Products Far Outpace R&D Costs, Study Finds
Newsletter
Where clinical, regulatory, and economic perspectives converge—sign up for Center for Biosimilars® emails to get expert insights on emerging treatment paradigms, biosimilar policy, and real-world outcomes that shape patient care.
